Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates

被引：21

作者：

Jain, Amita ^{[1
]}

Dixit, Pratima ^{[1
]}

Prasad, Rajendra ^{[2
]}

机构：

[1] CSM Med Univ, Dept Microbiol, Lucknow 226003, Uttar Pradesh, India

[2] CSM Med Univ, Dept Pulm Med, Lucknow 226003, Uttar Pradesh, India

来源：

TUBERCULOSIS | 2012年 / 92卷 / 05期

关键词：

M; tuberculosis; Drug resistance; MDR-TB; XDR-TB; Pre-; 2ND-LINE DRUG-RESISTANCE; MULTIDRUG; SURVEILLANCE; PREVALENCE; PATTERNS; STATE;

D O I：

10.1016/j.tube.2012.05.010

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Resistance to second line anti tubercular drugs is a cause of serious concern. The present study reports the prevalence of Ofloxacin (OFX) and Kanamycin (KM) resistance in Mycobacterium tuberculosis isolates from cases of pulmonary tuberculosis, who received anti tubercular treatment for >4 weeks in past. Of total 438 enrolled patients, 361 were culture positive for M. tuberculosis, of which, 95 (26.3%) were OFX resistant & 49 (13.5%) were KM resistant. Total 130 isolates were Multidrug resistant, of which, 55 (42.3%) were resistant to either OFX or KM (Pre-XDR) & 11 (8.5%) were resistant to both KM & OFX (XDR). Resistance to quinolones & aminoglycosides should be routinely assessed in areas endemic for tuberculosis. (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：404 / 406

页数：3

共 50 条

[31] Performance evaluation of AnyplexII MTB/MDR/XDR for detection of first and second-line drug resistance in Mycobacterium tuberculosis
Malinga, L. A.
Sibandze, B.
Tsireledzo, R.
Makhado, N.
Maluleka, C.
Magazi, B.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 45 : 35 - 35
[32] Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains
Hameed, H. M. Adnan
Islam, Md Mahmudul
Chhotaray, Chiranjibi
Wang, Changwei
Liu, Yang
Tan, Yaoju
Li, Xinjie
Tan, Shouyong
Delorme, Vincent
Yew, Wing W.
Liu, Jianxiong
Zhang, Tianyu
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2018, 8
[33] Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis
Perez-Garcia, F.
Ruiz-Serrano, M. J.
Lopez Roa, P.
Acosta, Fermin
Perez-Lago, Laura
Garcia-De-Viedma, D.
Bouza, E.
JOURNAL OF MICROBIOLOGICAL METHODS, 2017, 139 : 74 - 78
[34] Epidemiologic characteristics of MDR/XDR tuberculosis in Montenegro, from 2005 to 2018
Bojovic, O.
Gudelj, D.
Lucic, S.
Rakocevic, B.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 459 - 459
[35] Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China
Yu Pang
Haiyan Dong
Yaoju Tan
Yunfeng Deng
Xingshan Cai
Hui Jing
Hui Xia
Qiang Li
Xichao Ou
Biyi Su
Xuezheng Li
Zhiying Zhang
Junchen Li
Jiankang Zhang
Shitong Huan
Yanlin Zhao
Scientific Reports, 6
[36] Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China
Pang, Yu
Dong, Haiyan
Tan, Yaoju
Deng, Yunfeng
Cai, Xingshan
Jing, Hui
Xia, Hui
Li, Qiang
Ou, Xichao
Su, Biyi
Li, Xuezheng
Zhang, Zhiying
Li, Junchen
Zhang, Jiankang
Huan, Shitong
Zhao, Yanlin
SCIENTIFIC REPORTS, 2016, 6
[37] Mesenchymal Stromal Cell Therapy in MDR/XDR Tuberculosis: A Concise Review
Lavanya Joshi
Lakshmi Kiran Chelluri
Sumanlatha Gaddam
Archivum Immunologiae et Therapiae Experimentalis, 2015, 63 : 427 - 433
[38] Mesenchymal Stromal Cell Therapy in MDR/XDR Tuberculosis: A Concise Review
Joshi, Lavanya
Chelluri, Lakshmi Kiran
Gaddam, Sumanlatha
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2015, 63 (06) : 427 - 433
[39] Study of Promoter and Structural Gene Sequence of whiB7 in MDR and XDR forms of Mycobacterium tuberculosis
Arjomandzadegan, M.
Sadrnia, M.
Surkova, L. K.
Titov, L. P.
WEST INDIAN MEDICAL JOURNAL, 2011, 60 (03): : 251 - 256
[40] Evaluation of the GenoType® MTBDRsl assay in Korean patients with MDR or XDR tuberculosis
Jeong, Hyun Yong
Kim, Haeun
Kwon, Sunghoon
Ryoo, Sungweon
INFECTIOUS DISEASES, 2016, 48 (05) : 361 - 366

← 1 2 3 4 5 →